[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350365-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-350365-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","dysregulated-cell-signaling-pathways-in-prostate-tumoral-plasticitycheckpoints","Dysregulated Cell Signaling Pathways in Prostate Tumoral Plasticity—Checkpoints","","Deregulated plasticity drives initiation, progression, metastasis, and resistance to therapy across cancers. This study identifies new checkpoints linked to EMT heterogeneity and variability in prostate tumor cell plasticity. Cell signaling pathways were assessed using intrinsic and extrinsic factors, including cell-cycle profiling, apoptosis via caspase-3/7 activity, autophagy and nuclear shrinkage, immune evasion markers, and oxidative stress by flow cytometry, complemented by immunohistochemistry. Low or high S-proliferative categories predicted prognostic survival outcomes in BPH and prostate cancer.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/dysregulated-cell-signaling-pathways-in-prostate-tumoral-plasticitycheckpoints/350365/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/dysregulated-cell-signaling-pathways-in-prostate-tumoral-plasticitycheckpoints/350365.png","ImageObject",300,407,{"name":42,"@type":43},"Stanley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biological process does the study focus on in prostate tumors?","Question",{"text":63,"@type":64},"The study centers on dysregulated plasticity related to epithelial-mesenchymal transition (EMT) heterogeneity and tumor cell plasticity in prostate cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were apoptosis and other cellular events measured in the experiments?",{"text":68,"@type":64},"Apoptosis was assessed using caspase-3/7 biochemical cascade DEVDase activity with Magic Red stain and propidium iodide, with additional measurements for autophagy and nuclear shrinkage, immune evasion markers, and oxidative stress by flow cytometry.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cell-cycle category showed different prognostic roles in BPH versus prostate cancer?",{"text":72,"@type":64},"In benign prostatic hyperplasia, the low S-proliferative phase category predicted favorable survival, while in prostate cancer the high S-proliferative phase category predicted unfavorable survival.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},350365,1790292798,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},2336477405376,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[http://doi.org/10.32604/or.2026.072421](http://doi.org/10.32604/or.2026.072421)  \nARTICLE  \nDysregulated Cell Signaling Pathways in Prostate Tumoral  \nPlasticity—Checkpoints  \nElena Matei 1, *, Ionut, Ciprian Iorga2,3 , Mariana Deacu2,4 , Georgeta Camelia Cozaru 1,4 , Gabriela Isabela Băltătescu1,4,\\# and Manuela Enciu2,4,\\#  \n,  \n1 Center for Research and Development of the Morphological and Genetic Studies of Malignant Pathology,“Ovidius” University of Constanta, 145 Tomis Blvd., Constanta, Romania  \n2Medicine Faculty,“Ovidius” University of Constanta, 1 Universitatii Street, Constanta, Romania  \n3Urology Department,“Sf. Apostol Andrei” Emergency County Hospital, 145 Tomis Blvd., Constanta, Romania  \n4 Clinical Service of Pathology,“Sf. Apostol Andrei” Emergency County Hospital, 145 Tomis Blvd., Constanta, Romania  \n*Corresponding Author: Elena Matei. Email: [elena_matei@365.univ-ovidius.ro](elena_matei@365.univ-ovidius.ro)  \n[\\#](# These authors contributed equally to this work)[ These authors contributed equally to this work](# These authors contributed equally to this work)  \nReceived: 26 August 2025; Accepted: 02 February 2026; Published: 21 May 2026  \nABSTRACT: Objectives: Deregulated plasticity is involved in initiation, progression, metastasis, and resistance to therapy of various cancers. Our study aimed to present new checkpoints involved in complex biological processes that sustain epithelial-mesenchymal transition (EMT) variability and heterogeneity in prostate tumor cell plasticity. Methods: Dysregulated cell signaling pathways involved in prostate EMT heterogeneity were analyzed by intrinsic and extrinsic factors such as cell cycle phases by propidium iodide (PI) stain, apoptosis by caspase-3/7 biochemical cascade DEVDase enzyme activity by Magic Red stain (DEVD-MR)/propidium iodide stain, autophagy and nuclear shrinkage by Hoechst/acridine orange stain, evasion of immune surveillance by GPIba platelet glycoprotein conjugated with phycoerythrin (CD42b-PE) stain, oxidative stress by total reactive oxygen species (ROS) count by flow cytometry. Adaptation of the microenvironment involved in prostate EMT heterogeneity was analyzed by immunohistochemistry (IHC) . Results: In our study, in benign prostatic hyperplasia (BPH) tissue samples, the low S-proliferative phase category of the cell cycle (SH: \u003C7%) represents an independent predictor and a favorable prognostic biomarker for patient survival, as it is reported to dysregulate cell signaling pathways that characterize EMT heterogeneity. In prostate cancer tissue samples (PCa), the high S-proliferative phase category of the cell cycle (SCA, >12%) had an unfavorable prognostic role in patient survival rate, characteristically for EMT heterogeneity and aggressive phenotype involved in prostate tumoral cell plasticity, serving as a dependent predictor for the molecular mechanisms network, including late apoptosis, necrosis, autophagy, evasion of immune surveillance, cell cycle arrest in G0/G1 or G2/M phases, and oxidative stress. Conclusion: Low and high S-proliferative phase categories of the cell cycle, dysregulated early, late apoptosis via caspase-3/7 signaling pathway represent important checkpoints involved in EMT heterogeneity, and serve as independent or dependent predictor biomarkers for BPH and PCa patient prognostic survival rates, targeting personalized cancer therapy development.  \nKEYWORDS: Epithelial-mesenchymal transition (EMT); necrosis-apoptosis continuum; DNA damage; transcription factor p53; autophagy; microenvironment  \n1 Introduction  \nProstate lineage plasticity is a key driver of tumor progression, and epithelial-mesenchymal transition (EMT) heterogeneity plays an important role in regulating tumoral cellular plasticity [1–3] . Epithelial  \nCopyright © 2026 The Authors. Published by Tech Science Press. This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reprodu","cbCaitLQ1pVmm6DJ","https://ap.wps.com/l/cbCaitLQ1pVmm6DJ","pdf",4628320,33,"English","# Introduction\n## EMT heterogeneity and tumor plasticity\n## Apoptosis, necrosis, and molecular regulation\n## Cell-cycle and survival implications","[{\"question\":\"What biological process does the study focus on in prostate tumors?\",\"answer\":\"The study centers on dysregulated plasticity related to epithelial-mesenchymal transition (EMT) heterogeneity and tumor cell plasticity in prostate cancer.\"},{\"question\":\"How were apoptosis and other cellular events measured in the experiments?\",\"answer\":\"Apoptosis was assessed using caspase-3/7 biochemical cascade DEVDase activity with Magic Red stain and propidium iodide, with additional measurements for autophagy and nuclear shrinkage, immune evasion markers, and oxidative stress by flow cytometry.\"},{\"question\":\"Which cell-cycle category showed different prognostic roles in BPH versus prostate cancer?\",\"answer\":\"In benign prostatic hyperplasia, the low S-proliferative phase category predicted favorable survival, while in prostate cancer the high S-proliferative phase category predicted unfavorable survival.\"}]","Dysregulated Cell Signaling Pathways in Prostate Tumoral Plasticity—Checkpoints | PDF",1790088690,83,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/21a23c3d89e4246359fa594608ab8c69.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/718988624472867d47ce592b62016d9e.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a70b3d4b4925b48e2d543517c9953c36.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c7b167ee92dd9dcf0e14c5ba3cac0312.webp",980,1268]